NCT05338736View on ClinicalTrials.gov

Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 27, 2022

Study Completion Date

May 27, 2022

Conditions
SARS CoV 2 InfectionCOVID-19
Interventions
DIAGNOSTIC_TEST

LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)

Kit to test the concentration of Immunoglobulin G anti-SARS-CoV-2 in the plasma of included patients

DIAGNOSTIC_TEST

LIAISON SARS-CoV2-IgM (DiaSorin)

Kit to test the concentration of Immunoglobulin M anti-SARS-CoV-2 in the plasma of included patients

DIAGNOSTIC_TEST

Human IFN-g ELISpot PLUS (ALP) (AUROGENE)

Kit to test the cellular immunity response by measuring the Interferon gamma released by mononuclear cells (PBMCs)

Trial Locations (1)

Unknown

AOU Mater Domini, Catanzaro

All Listed Sponsors
lead

University Magna Graecia

OTHER